title: Expression of erythropoietin and its receptor in kidneys from normal and cyclosporine-treated rats.
abstract: Long-term treatment with cyclosporine A (CsA) is associated with various types of complications; however, CsA-induced anemia has not been reported. The present study examined the impact of CsA on hematopoietic parameters and intrarenal expression of erythropoietin (EPO) and the EPO receptor (EPOR) in a rat model of chronic CsA nephrotoxicity. Sprague-Dawley rats were fed a low-salt diet (0.05% sodium) and were treated daily for 4 weeks with vehicle (olive oil 1 mL/kg subcutaneously) or CsA (15 mg/kg subcutaneously). The expression of EPO and EPOR was evaluated by immunohistochemistry and immunoblotting, and hematopoietic parameters were assessed by measuring blood hemoglobin and hematocrit levels, and these variables were compared between treatment groups. Renal function, oxidative stress, histopathology (tubulointerstitial fibrosis), apoptotic cell death, and expression of transforming growth factor β-inducible gene-h3 (βig-h3) were also compared between treatment groups. In kidneys from vehicle-treated rats, endogenous EPO and EPOR protein were expressed constitutively in the outer stripe of the outer medulla and the cortex. EPO protein expression decreased significantly in kidneys from CsA-treated rats. By contrast, EPOR expression was higher in kidneys from CsA-treated rats than in vehicle-treated rats. These changes were accompanied by decreases in serum hemoglobin and hematocrit levels and correlated with the number of cells positive for terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (r = -0.769, P = .003) and βig-h3 protein expression (r = -0.910, P < .001). Long-term treatment with CsA suppresses renal endogenous EPO expression, resulting in anemia. Increases in apoptotic cell death and βig-h3 expression are closely associated with inhibition of EPO expression in chronic CsA nephrotoxicity.
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: D M
authors.initials: DM
authors.lastname: Lei
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China; Transplant Research Center, Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
authors.forename: S G
authors.initials: SG
authors.lastname: Piao
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: Y S
authors.initials: YS
authors.lastname: Jin
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: H
authors.initials: H
authors.lastname: Jin
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: Z H
authors.initials: ZH
authors.lastname: Cui
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: H F
authors.initials: HF
authors.lastname: Jin
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: J Z
authors.initials: JZ
authors.lastname: Jin
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: H L
authors.initials: HL
authors.lastname: Zheng
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: J J
authors.initials: JJ
authors.lastname: Li
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China.
authors.forename: Y J
authors.initials: YJ
authors.lastname: Jiang
authors.affiliation: Transplant Research Center, Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
authors.forename: C W
authors.initials: CW
authors.lastname: Yang
authors.affiliation: Nephrology and Dialysis Unit, Department of Internal Medicine, YanBian University Hospital, Jilin, China. Electronic address: lican@ybu.edu.cn.
authors.forename: C
authors.initials: C
authors.lastname: Li
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004921:Erythropoietin / Q000378:metabolism*; D020287:In Situ Nick-End Labeling; D007668:Kidney / Q000378:metabolism*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017467:Receptors, Erythropoietin / Q000378:metabolism*
chemical_list: D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D016572:Cyclosporine